Bellerophon Therapeutics Inc.

BLPH
Date Form Type SEC Filings
Mar 6, 2024 15-12G Profile Financial Statements
Mar 1, 2024 SCHEDULE 13G Profile Financial Statements
Feb 12, 2024 DEFA14A Profile Financial Statements
Jan 26, 2024 SCHEDULE 13G Profile Financial Statements
Jan 22, 2024 8-K Profile Financial Statements
Jan 3, 2024 DEFA14A Profile Financial Statements
Dec 27, 2023 25-NSE Profile Financial Statements
Nov 14, 2023 10-Q Profile Financial Statements
Nov 6, 2023 DEF 14A Profile Financial Statements
Oct 27, 2023 PRE 14A Profile Financial Statements
Oct 18, 2023 SC 13D/A Profile Financial Statements
Oct 17, 2023 SC 13D/A Profile Financial Statements
Oct 16, 2023 RW Profile Financial Statements
Oct 16, 2023 S-8 POS Profile Financial Statements
Oct 16, 2023 4 Profile Financial Statements
Oct 13, 2023 8-K Profile Financial Statements
Jul 24, 2023 8-K Profile Financial Statements
Jul 20, 2023 8-K Profile Financial Statements
Jul 14, 2023 8-K Profile Financial Statements
Jun 9, 2023 SC 13G/A Profile Financial Statements
Jun 9, 2023 EFFECT Profile Financial Statements
Jun 8, 2023 SC 13D/A Profile Financial Statements
Jun 7, 2023 4 Profile Financial Statements
Jun 7, 2023 144 Profile Financial Statements
Jun 7, 2023 S-8 Profile Financial Statements
Jun 5, 2023 8-K Profile Financial Statements
Jun 2, 2023 S-3 Profile Financial Statements
May 31, 2023 424B5 Profile Financial Statements
May 26, 2023 SC 13G/A Profile Financial Statements
May 18, 2023 144 Profile Financial Statements
Mar 31, 2023 10-K Profile Financial Statements
Mar 31, 2022 10-K Profile Financial Statements
Mar 11, 2021 10-K Profile Financial Statements
Apr 6, 2020 10-K Profile Financial Statements
Mar 14, 2019 10-K Profile Financial Statements
Mar 15, 2018 10-K Profile Financial Statements
Mar 13, 2017 10-K Profile Financial Statements
Mar 21, 2016 10-K Profile Financial Statements